jazz pharmaceuticals ireland limited - crisantaspase - prekursorisolujen lymfoblastinen leukemia-lymfooma - antineoplastiset aineet - enrylaze is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukaemia (all) and lymphoblastic lymphoma (lbl) in adult and paediatric patients (1 month and older) who developed hypersensitivity or silent inactivation to e. coli-derived asparaginase.
União Europeia -
finlandês -
EMA (European Medicines Agency)